Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

about

Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy.Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma

P2860

Q54112790-28C0F325-1EA5-4A19-A4CA-F2193464FFFB Q58129526-55C80160-BCB8-4951-8FAA-B2AEDF3A1990

P2860

Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

Item

http://www.wikidata.org/entity/Q38944791

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Innate adjuvant receptor Toll- ...... t cancer through cell surface.

@en

type

Item

label

Innate adjuvant receptor Toll- ...... t cancer through cell surface.

@en

prefLabel

Innate adjuvant receptor Toll- ...... t cancer through cell surface.

@en

P1476

Innate adjuvant receptor Toll- ...... t cancer through cell surface.

@en

P2093

Anupam Basu

http://www.w3.org/2001/XMLSchema#string

Anuradha Moirangthem

http://www.w3.org/2001/XMLSchema#string

Banashree Bondhopadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation.

P2888

s13277-014-2737-8

P304

1261-1271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-014-2737-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040400332

http://www.w3.org/2001/XMLSchema#string

P698

25348355

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

about

P2860

P2860

Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921